Literature DB >> 22527872

A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder.

Dan J Stein1, Nastassja Koen, Naomi Fineberg, Leonardo F Fontenelle, Hisato Matsunaga, David Osser, H Blair Simpson.   

Abstract

There is a need to synthesize the growing body of literature on the pharmacotherapeutic management of patients with obsessive-compulsive disorder for clinicians working at a primary care level. We have aimed to generate a simple, easy-to-follow algorithm for the primary care practitioner. This seven-step algorithm addresses diagnosis of obsessive-compulsive disorder, initiation of pharmacotherapy, monitoring and maintenance treatment, and guidelines for the management of patients who are resistant to initial therapy. In creating this algorithm, we have drawn on the body of published evidence, as well as on expert opinion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22527872     DOI: 10.1007/s11920-012-0268-9

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  81 in total

Review 1.  Antidepressants and body weight: a comprehensive review and meta-analysis.

Authors:  Alessandro Serretti; Laura Mandelli
Journal:  J Clin Psychiatry       Date:  2010-10       Impact factor: 4.384

2.  Venlafaxine in obsessive-compulsive disorder.

Authors:  J A Yaryura-Tobias; F A Neziroglu
Journal:  Arch Gen Psychiatry       Date:  1996-07

Review 3.  Gender differences in obsessive-compulsive disorder: a literature review.

Authors:  Maria Alice de Mathis; Pedro de Alvarenga; Guilherme Funaro; Ricardo Cezar Torresan; Ivanil Moraes; Albina Rodrigues Torres; Monica L Zilberman; Ana Gabriela Hounie
Journal:  Braz J Psychiatry       Date:  2011-12       Impact factor: 2.697

4.  Response versus remission in obsessive-compulsive disorder.

Authors:  Helen Blair Simpson; Jonathan D Huppert; Eva Petkova; Edna B Foa; Michael R Liebowitz
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

5.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

6.  High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.

Authors:  Philip T Ninan; Lorrin M Koran; Ari Kiev; Jonathan R T Davidson; Steven A Rasmussen; John M Zajecka; Delbert G Robinson; Paul Crits-Christoph; Francine S Mandel; Carol Austin
Journal:  J Clin Psychiatry       Date:  2006-01       Impact factor: 4.384

7.  Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.

Authors:  E Mundo; L Bianchi; L Bellodi
Journal:  J Clin Psychopharmacol       Date:  1997-08       Impact factor: 3.153

8.  Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.

Authors:  W A Hewlett; S Vinogradov; W S Agras
Journal:  J Clin Psychopharmacol       Date:  1992-12       Impact factor: 3.153

Review 9.  Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).

Authors:  G M Soomro; D Altman; S Rajagopal; M Oakley-Browne
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more
  17 in total

1.  Topiramate augmentation in a patient with obsessive-compulsive disorder.

Authors:  Michael Van Ameringen; Beth Patterson
Journal:  J Psychiatry Neurosci       Date:  2015-09       Impact factor: 6.186

2.  Repetitive transcranial magnetic stimulation (rTMS) augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant obsessive-compulsive disorder (OCD): a meta-analysis of randomized controlled trials.

Authors:  Zhong-Rui Ma; Li-Jun Shi
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 3.  A Meta-Analysis of the Effectiveness of Different Cortical Targets Used in Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Obsessive-Compulsive Disorder (OCD).

Authors:  Simone Rehn; Guy D Eslick; Vlasios Brakoulias
Journal:  Psychiatr Q       Date:  2018-09

4.  Long-term electrical stimulation of bed nucleus of stria terminalis for obsessive-compulsive disorder.

Authors:  S Raymaekers; K Vansteelandt; L Luyten; C Bervoets; K Demyttenaere; L Gabriëls; B Nuttin
Journal:  Mol Psychiatry       Date:  2016-08-02       Impact factor: 15.992

5.  Role of lamotrigine augmentation in treatment-resistant obsessive compulsive disorder: a retrospective case review from South Asia.

Authors:  Arshad Hussain; Mansoor Ahmad Dar; Rayees Ahmad Wani; Majid Shafi Shah; Mohd Muzzaffar Jan; Yasir A Malik; Rajesh Kumar Chandel; Mushtaq Ahmad Margoob
Journal:  Indian J Psychol Med       Date:  2015 Apr-Jun

6.  [Help-seeking behavior and pathways to care for patients with obsessive-compulsive disorders].

Authors:  P Mavrogiorgou; F Siebers; T Kienast; G Juckel
Journal:  Nervenarzt       Date:  2015-09       Impact factor: 1.214

Review 7.  Assessment and management of treatment-refractory obsessive-compulsive disorder in children.

Authors:  Michael H Bloch; Eric A Storch
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2015-01-30       Impact factor: 8.829

Review 8.  DISSECTING OCD CIRCUITS: FROM ANIMAL MODELS TO TARGETED TREATMENTS.

Authors:  Susanne E Ahmari; Darin D Dougherty
Journal:  Depress Anxiety       Date:  2015-05-07       Impact factor: 6.505

Review 9.  Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.

Authors:  David Veale; Sarah Miles; Nicola Smallcombe; Haben Ghezai; Ben Goldacre; John Hodsoll
Journal:  BMC Psychiatry       Date:  2014-11-29       Impact factor: 3.630

10.  Lamotrigine augmentation of serotonin reuptake inhibitors in severe and long-term treatment-resistant obsessive-compulsive disorder.

Authors:  Manuel Arrojo-Romero; María Tajes Alonso; Jose de Leon
Journal:  Case Rep Psychiatry       Date:  2013-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.